“…Furthermore, it has been suggested that rates of PNI are higher in cSCCs of the head and neck (H&N) compared to other anatomic sites which may confound past reports (Chang et al, 2004). Comparisons of PNI incidence are complicated by multiple factors that include the challenges associated with detection of PNI using hematoxylin and eosin (H&E) staining (obscured nerve and morphologically imperceptible tumor cells), lack of a standardized histological definition of PNI (delineating true PNI from focal abutment secondary to impingement of nerve by tumor), differences in detection rates between cryostat and formalinfixed paraffin-embedded tissue sections (Mohs micrographic surgery vs traditional histopathologic examination), and histological mimics such as Renault bodies, perineural fibrosis, reactive neuroepithelial aggregates, and reparative perineural hyperplasia (Campoli et al, 2014;Dunn, Morgan, Beer, Chen, & Acker, 2009;Hassanein et al, 2005;Kurtz, Hoffman, Zimmerman, & Robinson, 2005;Ronaghy, Yaar, Goldberg, Mahalingam, & Bhawan, 2010;Zhou, Xu, Zhang, Zhao, & Wu, 2014). Lastly, in select cutaneous and noncutaneous malignancies it has been shown that the use of immunohistochemistry (IHC) can aid in the detection of PNI, especially in the tumor bulk where nerve can be obscured by tumor (intratumoral PNI) (Berlingeri-Ramos, Detweiler, Wagner, & Kelly, 2015;Kurtz et al, 2005;Scanlon et al, 2014;Zhou et al, 2014).…”